Sunday 06 Oct, 2024 03:43 PM
Site map | Locate Us | Login
   Avantel Q2 PAT jumps 42% YoY to Rs 23 cr    Equitas SFB total deposits jump 29% YoY in Q2 FY25    Ujjivan SFB total deposits rises 17% in Q2 FY25    L&T Finance retail disbursements jump 12% YoY in Q2 FY25    Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore    Lupin's Pune-based biotech facility gets 5 observations from US FDA    Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25    UCO Bank's total advances jump 19% YoY in Q2 FY25    Vakrangee Ltd leads losers in 'A' group    GRSE bags Rs 226-cr LoA from West Bengal Govt    Kamdhenu Ventures Ltd leads losers in 'B' group    Volumes soar at Avenue Supermarts Ltd counter    Utilties stocks edge lower    Auto stocks edge lower    Real Estate stocks edge lower 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Lupin's Pune-based biotech facility gets 5 observations from US FDA
05-Oct-24   13:20 Hrs IST

The inspection was carried out from 25 September 2024 to 04 October 2024, and concluded with five observations.

The company is addressing the observations comprehensively and will respond to the U.S. FDA within the stipulated timeframe.

Mumbai-based Lupin is an innovation-led transnational pharmaceutical company. It develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.

The company's consolidated net profit jumped 76.01% to Rs 801.31 crore during the quarter as compared with Rs 452.26 crore posted in Q1 FY24. Revenue from operations increased 16.28% YoY to Rs 5,514.34 crore during the quarter.

The scrip had advanced 0.65% to end at Rs 2197.60 on the BSE on Friday.

Powered by Capital Market - Live News
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Investor Charter | Annual Return | Span Margin | Disclaimer | Feed Back | Privacy Policy | Policies & Procedures |DP Closure| |Rights & Obligations-English| Rights & Obligations-தமிழ் | Anti Money Laundering Policy | E-Voting | CSR | Voluntary Freezing / Blocking Hit Count : 35941748
Useful Links : NSE | BSE | MCX | NSDL | CDSL | SEBI | RBI | ATTENTION INVESTOR| SMART ODR
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd